Lou, Z.; Wang, X.; Hu, C.; Liu, W.; Ji, Y. Combination of Anlotinib and Second-Line Chemotherapy As Surrogate to Reduce Immunosuppression in Patients With Advanced Non-Small Cell Lung Cancer. Pak J Med Sci 2024, 40.